Lombard Odier Asset Management (Switzerland) Sa Guardant Health, Inc. Transaction History

Lombard Odier Asset Management (Switzerland) Sa

$1.14 Billion
Q3 2024

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	BUY	$22.92 - $33.76 $3.99 Million - $5.88 Million	174,244 Added 186.37%	267,739 $6.28 Million
Q4 2022 Feb 14, 2023	BUY	$25.44 - $59.78 $1.87 Million - $4.39 Million	73,454 Added 366.52%	93,495 $2.54 Million
Q3 2022 Nov 14, 2022	BUY	$43.66 - $61.0 $874,990 - $1.22 Million	20,041 New	20,041 $1.08 Million

Others Institutions Holding GH

# of Institutions

323

Shares Held

127M

Call Options Held

844K

Put Options Held

2.38M

Vanguard Group Inc Valley Forge, PA

11.7M
Shares

$550 Million
0.0% of portfolio
Black Rock Inc. New York, NY

11.2M
Shares

$528 Million
0.01% of portfolio
Wellington Management Group LLP Boston, MA

10.1M
Shares

$476 Million
0.04% of portfolio
Cadian Capital Management, LP New York, NY

6.93M
Shares

$326 Million
8.13% of portfolio
Deep Track Capital, LP Greenwich, CT

6M
Shares

$282 Million
5.07% of portfolio

View Full List

About Guardant Health, Inc.

Ticker GH
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 102,220,000
Market Cap $4.8B
Description
Guardant Health, Inc., a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally. The company offers Guardant360, Guardant360 LDT, Guardant360 CDx, and GuardantOMNI liquid biopsy-based tests for advanced stage cancer; and GuardantINFORM, an in-silico research platform that comprise a cl...

More about GH

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Lombard Odier Asset Management (Switzerland) Sa, based on Form 13F filings with the SEC.

News

Stay updated on Lombard Odier Asset Management (Switzerland) Sa with notifications on news.

Account